Trials / Conditions / Non-arteritic Anterior Ischemic Optic Neuropathy
Non-arteritic Anterior Ischemic Optic Neuropathy
6 registered clinical trials studyying Non-arteritic Anterior Ischemic Optic Neuropathy — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic NCT07453888 | Dompé Farmaceutici S.p.A | Phase 3 |
| Completed | Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) NCT03046693 | Valen Chia | Phase 4 |
| Terminated | Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic An NCT02341560 | Quark Pharmaceuticals | Phase 2 / Phase 3 |
| Completed | Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patie NCT01064505 | Quark Pharmaceuticals | Phase 1 |
| Unknown | Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy NCT00813059 | Mount Sinai Hospital, Canada | Phase 2 |
| Completed | Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy NCT00140491 | Emory University | N/A |